Do not combine weight loss medications on your own
Tirzepatide, a dual GIP and GLP-1 receptor agonist approved by the FDA for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound), may indirectly affect menstrual cycles in some women
Whether you are on a GLP-1 medication or prefer a natural approach, this patch helps support metabolic health without pills, powders, or side effects
The drug also helps people get better insulin sensitivity, and that is good for those who have diabetes or health conditions linked to their metabolism
Instead of taking risks, choose safe, effective alternatives that are already FDA-approved
They will be offered to people based on factors beyond BMI, including genuine metabolic health risks, like sleep apnea or high blood pressure, the company said